Von dem Buch Ticlopidine, platelets and vascular disease. ; J. Donald Easton, ed. haben wir 3 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Hass, William K. [Hrsg.]: Ticlopidine, platelets and vascular disease. ; J. Donald Easton, ed. (ISBN: 9783540940098) 1993, in Deutsch, Broschiert.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
81%: J.Donald Easton, William K. Hass: Ticlopidine, Platelets and Vascular Disease (ISBN: 9781461383062) Springer, Springer, Springer, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
65%: William K. Hass; J.Donald Easton: Ticlopidine, Platelets and Vascular Disease (ISBN: 9781461383086) Springer Science+Business Media, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
Ticlopidine, platelets and vascular disease. ; J. Donald Easton, ed.
10 Angebote vergleichen
Bester Preis: € 30,00 (vom 15.06.2016)1
Ticlopidine, Platelets and Vascular Disease (2015)
EN NW EBISBN: 9781461383062 bzw. 1461383064, in Englisch, Springer New York, neu, E-Book.
Lieferung aus: Niederlande, Direct beschikbaar.
bol.com.
Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent year... Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease. Productinformatie:Taal: Engels;Formaat: ePub met kopieerbeveiliging (DRM) van Adobe;Kopieerrechten: Het kopiëren van (delen van) de pagina's is niet toegestaan ;Geschikt voor: Alle e-readers te koop bij bol.com (of compatible met Adobe DRM). Telefoons/tablets met Google Android (1.6 of hoger) voorzien van bol.com boekenbol app. PC en Mac met Adobe reader software;ISBN10: 1461383064;ISBN13: 9781461383062; Engels | Ebook | 2015.
bol.com.
Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent year... Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas cular coagulation which often underlies such major diseases as myocardial infarc tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease. Productinformatie:Taal: Engels;Formaat: ePub met kopieerbeveiliging (DRM) van Adobe;Kopieerrechten: Het kopiëren van (delen van) de pagina's is niet toegestaan ;Geschikt voor: Alle e-readers te koop bij bol.com (of compatible met Adobe DRM). Telefoons/tablets met Google Android (1.6 of hoger) voorzien van bol.com boekenbol app. PC en Mac met Adobe reader software;ISBN10: 1461383064;ISBN13: 9781461383062; Engels | Ebook | 2015.
2
Ticlopidine, Platelets and Vascular Disease (2012)
EN NW EB DLISBN: 9781461383062 bzw. 1461383064, in Englisch, Springer, Springer, Springer, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, in-stock.
Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate- lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas- cular coagulation which often underlies such major diseases as myocardial infarc- tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten- sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.
Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate- lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas- cular coagulation which often underlies such major diseases as myocardial infarc- tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten- sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.
3
Ticlopidine, platelets and vascular disease. ; J. Donald Easton, ed. (1993)
DE USISBN: 9783540940098 bzw. 354094009X, in Deutsch, New York ; Berlin ; Heidelberg ; London ; Paris ; Tokyo ; Hong Kong ; Barcelona ; Budapest : Springer, gebraucht.
Von Händler/Antiquariat, Antiquariat Udo Schwörer [2791014], Pforzheim, Germany.
XI, 162 S. : graph. Darst. ; 24 cm 354094009X Sprache: Englisch.
XI, 162 S. : graph. Darst. ; 24 cm 354094009X Sprache: Englisch.
4
Ticlopidine, platelets and vascular disease. J. Donald Easton, ed. (1993)
DE USISBN: 9783540940098 bzw. 354094009X, in Deutsch, New York Berlin Heidelberg London Paris Tokyo Hong Kong Barcelona Budapest : Springer, gebraucht.
Lieferung aus: Deutschland, Versandkosten nach: Deutschland.
Von Händler/Antiquariat, Antiquariat Schwörer, [3177159].
XI, 162 S. : graph. Darst. 24 cm OPd 354094009X, gebraucht gut.
Von Händler/Antiquariat, Antiquariat Schwörer, [3177159].
XI, 162 S. : graph. Darst. 24 cm OPd 354094009X, gebraucht gut.
5
Ticlopidine, Platelets and Vascular Disease
EN NWISBN: 9781461383086 bzw. 1461383080, in Englisch, Springer New York, neu.
Lieferung aus: Kanada, In Stock, plus shipping.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
Ticlopidine, Platelets and Vascular Disease
EN NWISBN: 9781461383086 bzw. 1461383080, in Englisch, Springer Science+Business Media, neu.
Lieferung aus: Vereinigte Staaten von Amerika, In Stock.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
Ticlopidine, Platelets and Vascular Disease
EN PB NWISBN: 9781461383086 bzw. 1461383080, in Englisch, Springer New York, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, In Stock.
Ticlopidine-Platelets-and-Vascular-Disease~~William-K-Hass, Ticlopidine, Platelets and Vascular Disease, Paperback.
Ticlopidine-Platelets-and-Vascular-Disease~~William-K-Hass, Ticlopidine, Platelets and Vascular Disease, Paperback.
Lade…